Tandem Diabetes Care Inc (TNDM) — Capital Reinvestment Ratio
Latest as of March 2026:
0.57x
Tandem Diabetes Care Inc (TNDM) has a Capital Reinvestment Ratio of 0.57x as of March 2026, meaning it reinvests 1% of its operating cash flow ($11.05 Million) in capital expenditures ($6.27 Million). See Tandem Diabetes Care Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.57x
Capex / Operating Cash Flow
Operating Cash Flow
$11.05 Million
USD
Capital Expenditures
$6.27 Million
USD
Data as of
Mar 2026
Most recent filing
Tandem Diabetes Care Inc Capital Reinvestment Ratio (2019–2024)
This chart tracks Tandem Diabetes Care Inc's Capital Reinvestment Ratio across 5 annual periods.
Annual Capital Reinvestment Ratio for Tandem Diabetes Care Inc (2019–2024)
Year-by-year Capital Reinvestment Ratio for Tandem Diabetes Care Inc from 2019 to 2024. For live market cap and broader valuation context, see Tandem Diabetes Care Inc stock valuation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.79x | $24.23 Million | $19.23 Million | ▲ +17.5% |
| 2022 | 0.68x | $50.46 Million | $34.10 Million | ▲ +220.0% |
| 2021 | 0.21x | $111.36 Million | $23.51 Million | ▼ -83.9% |
| 2020 | 1.31x | $24.67 Million | $32.29 Million | ▲ +180.7% |
| 2019 | 0.47x | $41.91 Million | $19.54 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow